The starch-bound alpha-amylase/trypsin-inhibitors in Avena
- 5 August 2016
- journal article
- research article
- Published by Springer Nature in Molecular Genetics and Genomics
- Vol. 291 (6) , 2043-2054
Abstract
Oat kernels exhibit an extra-soft texture, a trait recently demonstrated to be largely modulated by starch-bound tryptophan-rich 2S proteins, the vromindolines. In this study, fractionation by two-dimensional electrophoresis of starch-bound proteins in 25 oat (Avena sativa) cultivars and 11 diploid or tetraploid Avena species revealed novel 2S proteins called Avena α-amylase/trypsin-inhibitors (AATI) because of their sequence similarity with wheat α-amylase/trypsin inhibitors. Thirty-seven AATI polypeptides, about 14 kDa in size, were split into three families named AATI-1, AATI-2, and AATI-3 with different primary structures and isoelectric points. AATI-1 and AATI-2 proteins showed 55.5–60.0 % sequence similarity with wheat α-amylase inhibitors CM1, CM2, and CM16, which have been found to cause innate immunity responses in celiac disease and non-celiac gluten sensitivity. Diploid A-genome and tetraploid AC-genome oat species possess three and five genes encoding for the AATI proteins, respectively, whereas hexaploid A. sativa exhibits 12 genes dispersed over the A-, C-, and D-genomes. Some AATI proteins expressed in hexaploid oats were assigned to the A-genome based on similarity to their counterparts in diploid species, contributing to further clarify the genetic origin of hexaploid oats. Moreover, AATI may interact with starch-bound vromindolines in determining the extra-soft texture of oat kernels and, due to their balanced amino acid compositions, may contribute to the biological value of oat proteins in a positive manner.Keywords
This publication has 33 references indexed in Scilit:
- Avena sativa(Oat), A Potential Neutraceutical and Therapeutic Agent: An OverviewCritical Reviews in Food Science and Nutrition, 2013
- Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of toll-like receptor 4Journal of Experimental Medicine, 2012
- Immunogenicity of two oat varieties, in relation to their safety for celiac patientsScandinavian Journal of Gastroenterology, 2011
- Molecular characterisation of 36 oat varieties and in vitro assessment of their suitability for coeliacs’ dietJournal of Cereal Science, 2011
- Celiac disease, gluten-free diet, and oatsNutrition Reviews, 2011
- Potential health benefits of avenanthramides of oatsNutrition Reviews, 2009
- Coeliac disease and oats: a systematic reviewPostgraduate Medical Journal, 2006
- A major baker's asthma allergen from rye flour is considerably more active than its barley counterpartFEBS Letters, 1995
- Genomic in situ hybridization in Avena sativaGenome, 1994
- Three inhibitor types from wheat endosperm are differentially active against ?-amylases of Lepidoptera pestsEntomologia Experimentalis et Applicata, 1993